ArticleBioengineered2021

Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6.

Ying WangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.